Word

ALOOP

Status

Dead

Status Code

602

Status Date

Thursday, March 14, 2024

Serial Number

97704450

Mark Type

3000

Filing Date

Monday, December 5, 2022

Abandoned Date

Friday, March 1, 2024

Trademark Owner History

Aloop Therapeutics ApS

Classifications

5 Medicine for the treatment, prevention, or alleviation of rare and genetic diseases, cancer, precancerous diseases and benign tumors, diabetes, autoimmune diseases, inflammatory diseases, infectious diseases, neurodegenerative diseases, neuromuscular disorders, psychiatric disorders, movement disorders, extrapyramidal disorders, hyperkinetic movement disorders, hypokinetic movement disorders, parkinsonism, Parkinson's disease, sclerosis, gastrointestinal disorders and diseases, diarrhea, metabolic diseases, inborn Errors of Metabolism, lysosomal Storage Diseases, urea cycle disorders, cardiovascular diseases, neurodevelopmental disorders, cardiometabolic diseases

42 Research and development of vaccines and medicines

The mark consists of the stylized wording "ALOOP" wherein the colors transition from green to teal to blue from left to right and the "OO" forms an infinity symbol.
A LOOP
The color(s) green, teal, and blue is/are claimed as a feature of the mark.

Trademark Events

Mar 14, 2024

Abandonment Notice E-Mailed - Failure To Respond

Mar 14, 2024

Abandonment - Failure To Respond Or Late Response

Nov 29, 2023

Notification Of Non-Final Action E-Mailed

Nov 29, 2023

Non-Final Action E-Mailed

Nov 29, 2023

Non-Final Action Written

Nov 3, 2023

Teas/Email Correspondence Entered

Nov 3, 2023

Correspondence Received In Law Office

Nov 2, 2023

Teas Response To Office Action Received

Sep 14, 2023

Notification Of Non-Final Action E-Mailed

Sep 14, 2023

Non-Final Action E-Mailed

Sep 14, 2023

Non-Final Action Written

Sep 12, 2023

Assigned To Examiner

Jul 18, 2023

Preliminary/Voluntary Amendment - Entered

Jul 18, 2023

Assigned To Lie

Mar 14, 2023

Teas Voluntary Amendment Received

Jan 4, 2023

Notice Of Design Search Code E-Mailed

Jan 3, 2023

New Application Office Supplied Data Entered

Dec 8, 2022

New Application Entered